Retrospective Chart Review of Joint Outcomes and Hospital Utilization for Persons with Hemophilia A (with and without inhibitors) Who Were Switched to Emicizumab for Treatment Prophylaxis

This research project will illustrate the improvements to joint range of motion and hospital utilization (which includes emergency room visits, hospital admissions, and central line infections) in persons with hemophilia A (with and without inhibitors) who switched to emicizumab for bleeding prevention.